NEW YORK , Aug. 22, 2024 /PRNewswire/ -- The global cell culture market size is estimated to grow by USD 24.8 billion from 2024-2028, according to Technavio.
The market is estimated to grow at a CAGR of almost 13.64% during the forecast period. Increase in infectious diseases is driving market growth, with a trend towards increasing demand for 3D cell culture.
However, contamination of cell culture poses a challenge. Key market players include Agilent Technologies Inc., Avantor Inc.
, Becton Dickinson and Co., Bio Techne Corp., CLS Cell Lines Service GmbH, Corning Inc.
, Danaher Corp., Eppendorf SE, FUJIFILM Holdings Corp., General Electric Co.
, InvivoGen Corp., LABGENE Scientific SA, Lonza Group Ltd., Merck KGaA, Miltenyi Biotec B.
V. And Co. KG, PromoCell GmbH, Sartorius AG, Sartorius CellGenix GmbH, Thermo Fisher Scientific Inc.
, and ZenBio Inc.. Get a detailed analysis on regions, market segments, customer landscape, and companies- View the snapshot of this report Market Driver The 3D cell culture market is experiencing significant growth due to the increasing adoption of this technology in various research fields.
In 3D cell culture, biological cells are grown in an artifically created environment that closely resembles normal cell morphology. This process is particularly useful for studying stem cells, viral pathogenesis, and cancer research. Companies like Thermo Fisher Scientific and Merck KGaA provide advanced 3D culture products to meet the growing demand.
Merck KGaA o.